224 related articles for article (PubMed ID: 29356992)
41. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
[TBL] [Abstract][Full Text] [Related]
42. Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice.
Chang HW; Lin YW; Ho HM; Lin MH; Liu CC; Shao HY; Chong P; Sia C; Chow YH
PLoS One; 2013; 8(7):e69858. PubMed ID: 23936115
[TBL] [Abstract][Full Text] [Related]
43. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
44. Development and evaluation of rapid point-of-care tests for detection of Enterovirus 71 and Coxsackievirus A16 specific immunoglublin M antibodies.
Zhang J; Weng Z; Du H; Xu F; He S; He D; Cheng T; Zhang J; Ge S; Xia N
J Virol Methods; 2016 May; 231():44-7. PubMed ID: 26912234
[TBL] [Abstract][Full Text] [Related]
45. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement.
Huang SW; Wang YF; Yu CK; Su IJ; Wang JR
Virology; 2012 Jan; 422(1):132-43. PubMed ID: 22078110
[TBL] [Abstract][Full Text] [Related]
46. Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms.
Ye X; Ku Z; Liu Q; Wang X; Shi J; Zhang Y; Kong L; Cong Y; Huang Z
J Virol; 2014 Jan; 88(1):72-81. PubMed ID: 24131712
[TBL] [Abstract][Full Text] [Related]
47. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps.
Ku Z; Ye X; Huang X; Cai Y; Liu Q; Li Y; Su Z; Huang Z
PLoS One; 2013; 8(2):e57601. PubMed ID: 23451250
[TBL] [Abstract][Full Text] [Related]
48. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
[TBL] [Abstract][Full Text] [Related]
49. Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71.
Huang KA; Zhou D; Fry EE; Kotecha A; Huang PN; Yang SL; Tsao KC; Huang YC; Lin TY; Ren J; Stuart DI
Nat Commun; 2020 Oct; 11(1):5253. PubMed ID: 33067459
[TBL] [Abstract][Full Text] [Related]
50. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.
Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443
[TBL] [Abstract][Full Text] [Related]
51. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection.
Lim XF; Jia Q; Khong WX; Yan B; Premanand B; Alonso S; Chow VT; Kwang J
PLoS One; 2012; 7(1):e29751. PubMed ID: 22279543
[TBL] [Abstract][Full Text] [Related]
52. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
[TBL] [Abstract][Full Text] [Related]
53. Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine.
Li J; Liu G; Liu X; Yang J; Chang J; Zhang W; Yu XF
Viruses; 2015 Jul; 7(7):3891-909. PubMed ID: 26193302
[TBL] [Abstract][Full Text] [Related]
54. A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential.
Zhou B; Xu L; Zhu R; Tang J; Wu Y; Su R; Yin Z; Liu D; Jiang Y; Wen C; You M; Dai L; Lin Y; Chen Y; Yang H; An Z; Fan C; Cheng T; Luo W; Xia N
Antiviral Res; 2019 Jan; 161():28-35. PubMed ID: 30419253
[TBL] [Abstract][Full Text] [Related]
55. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.
Kolpe AB; Kiener TK; Grotenbreg GM; Kwang J
Virus Res; 2012 Sep; 168(1-2):64-72. PubMed ID: 22728446
[TBL] [Abstract][Full Text] [Related]
56. Identification of specific antigenic epitope at N-terminal segment of enterovirus 71 (EV-71) VP1 protein and characterization of its use in recombinant form for early diagnosis of EV-71 infection.
Zhang J; Jiang B; Xu M; Dai X; Purdy MA; Meng J
Virus Res; 2014 Aug; 189():248-53. PubMed ID: 24952304
[TBL] [Abstract][Full Text] [Related]
57. Phage Display-Derived Cross-Reactive Neutralizing Antibody against Enterovirus 71 and Coxsackievirus A16.
Zhang X; Sun C; Xiao X; Pang L; Shen S; Zhang J; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
Jpn J Infect Dis; 2016; 69(1):66-74. PubMed ID: 26073737
[TBL] [Abstract][Full Text] [Related]
58. Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.
Gong M; Zhu H; Zhou J; Yang C; Feng J; Huang X; Ji G; Xu H; Zhu P
J Virol; 2014 Jun; 88(11):6444-52. PubMed ID: 24672036
[TBL] [Abstract][Full Text] [Related]
59. [A pathogen analysis within 174 cases of hand-foot-mouth disease in the summer of 2009].
Fu J; Cui XD; Sun CR; Wang TY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):377-80. PubMed ID: 22338230
[TBL] [Abstract][Full Text] [Related]
60. [Study on the association of hand, foot and mouth disease and enterovirus 71/CA16 among children in Beijing, 2007].
Zhu RN; Qian Y; Deng J; Xing JF; Zhao LQ; Wang F; Liao B; Ren XX; Li Y; Zhang Q; Li J
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):1004-8. PubMed ID: 18399150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
